Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (41-50 of 286) with videos related to

Pageof 29
Sort By:
Immunological Reviews|August 13, 2019
Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatmentRyan M Young, James D Phelan, Wyndham H Wilson, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision MedicineApostolia M Tsimberidou, Rabih Said, Louis M Staudt, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Oncogene|December 17, 2002
The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathwayDemetrios Kalaitzidis, R Eric Davis, Andreas Rosenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
IRF4: Immunity. Malignancy! Therapy?Arthur L Shaffer, N C Tolga Emre, Paul B Romesser, et al.
Science Advances|March 30, 2022
Structure of S1PR2-heterotrimeric G<sub>13</sub> signaling complexHongwen Chen, Kevin Chen, Weijiao Huang, et al.
Cell|April 2, 2021
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatmentHenry Rodriguez, Jean Claude Zenklusen, Louis M Staudt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2003
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphomaGeorge Wright, Bruce Tan, Andreas Rosenwald, et al.
Immunity|August 22, 2006
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiationRoger Sciammas, A L Shaffer, Jonathan H Schatz, et al.
The Journal of Experimental Medicine|April 4, 2007
Repression of BCL-6 is required for the formation of human memory B cells in vitroTracy C Kuo, Arthur L Shaffer, Joseph Haddad, et al.
Pageof 29

Showing results (41-50 of 286) with videos related to

Sort By:
Pageof 29
Immunological Reviews|August 13, 2019
Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatmentRyan M Young, James D Phelan, Wyndham H Wilson, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision MedicineApostolia M Tsimberidou, Rabih Said, Louis M Staudt, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Oncogene|December 17, 2002
The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathwayDemetrios Kalaitzidis, R Eric Davis, Andreas Rosenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
IRF4: Immunity. Malignancy! Therapy?Arthur L Shaffer, N C Tolga Emre, Paul B Romesser, et al.
Science Advances|March 30, 2022
Structure of S1PR2-heterotrimeric G<sub>13</sub> signaling complexHongwen Chen, Kevin Chen, Weijiao Huang, et al.
Cell|April 2, 2021
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatmentHenry Rodriguez, Jean Claude Zenklusen, Louis M Staudt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2003
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphomaGeorge Wright, Bruce Tan, Andreas Rosenwald, et al.
Immunity|August 22, 2006
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiationRoger Sciammas, A L Shaffer, Jonathan H Schatz, et al.
The Journal of Experimental Medicine|April 4, 2007
Repression of BCL-6 is required for the formation of human memory B cells in vitroTracy C Kuo, Arthur L Shaffer, Joseph Haddad, et al.
Pageof 29